Cycloheximide inhibits light-induced phase shifting of the circadian clock and protein synthesis in Neurospora. Light resetting is not inhibited in mutants whose protein synthesis is resistant to cycloheximide. When light and cycloheximide are presented together at various circadian phases, the final phase shift is always determined by cycloheximide. This dual-treatment phase response curve approach may be useful for other studies using pharmacological treatments to analyze clock pathways. Taken together, the results suggest that synthesis of a protein (or proteins) is involved in the phototransduction pathway of the circadian clock in Neurospora.
The cellular basis of circadian rhythmicity is unknown. An approach to discovering this biochemical clockwork is to characterize the phototransduction pathway by which the clock synchronizes to the daily light-dark cycle, so as to follow the photon information to the oscillating mechanism itself (Eskin, 1979; Johnson and Hastings, 1986) . One way to identify steps in the transduction pathway is to determine whether site-specific drugs can inhibit phase resetting by light (or another stimulus); if so, such results suggest that the site targeted by the drug contributes to a step in the transduction path. This approach has yielded valuable information about the transduction pathways of light and the neurotransmitter serotonin into the clockwork of the Aplysia eye (Eskin, 1977; Eskin et al., 1984) . As Eskin (1979) points out, the results of experiments using drugs to inhibit phase shifting by another stimulus (e.g., light) are easiest to interpret if the drug does not itself reset the oscillator.
Neurospora is an excellent system in which to analyze the clock's entrainment pathway. Light-induced phase shifting has been extensively characterized (Sargent and Briggs, 1967; Dharmananda, 1980; Feldman and Dunlap, 1983) . The photopigment seems to be of the &dquo;blue-light photoreceptor&dquo; class (Senger, 1980) . Pharmacological analyses of Neurospora phototransduction are facilitated by a liquid culture system that allows the simultaneous treatment of cultures with drugs and light (Nakashima, 1981) . This system has made possible experiments that have identified several membrane-active agents inhibiting phase resetting by light (Nakashima, 1982; Nakashima and Fujimura, 1982) .
Because Eskin and coworkers have found that protein synthesis appears to be necessary for transduction of clock resetting by serotonin (Eskin et al., 1984; Yeung and Eskin, 1987) , we wondered whether protein synthesis might be involved in light resetting of Neurospora's s clock. We report herein that the protein synthesis inhibitor cycloheximide does indeed prevent phase shifting of the Neurospora clock by light pulses. This result suggests that synthesis of some protein or proteins is necessary for conversion of the light signal into a phase shift of this circadian clock.
MATERIALS AND METHODS
&dquo;Discs&dquo; of Neurospora crassa mycelia were cultured as described previously (Nakashima, 1981) , except that the medium used was Vogel's salts medium instead of Fries's salts. As in that paper, the carbon sources were glucose and arginine. Temperature was 25-26°C. Light and/or drug treatments were given to discs in liquid culture, after which the drug was removed by blotting discs onto filter paper. Then the discs were inoculated onto race tubes to assay the phase of the circadian clock by the method of Dharmananda and Feldman (1979) . Sometimes discs were washed with Vogel's salts medium (no carbon source) after the light and/or drug treatment. Results were not significantly different between experiments in which discs were washed with Vogel's salts medium and in which discs were inoculated directly onto race tubes without washing.
Incorporation of [14C]leucine was assayed by the method described in Nakashima et al. (1981a) . All manipulations after the light-to-dark transition were performed under red safelight: either 30-W white fluorescent lamps with red plate filters (Acrylite 102, Mitsubishi) or red fluorescent light bulbs (General Electric) wrapped with red acetate film (Roscolux #19). Light-induced phase shifts were elicited by 2-min pulses of cool-white fluorescent light (100 lux). Neurospora crassa strains bdA and bd,cyh-I were obtained from Dr. J. F.
Feldman.

RESULTS
CYCLOHEXIMIDE INHIBITS LIGHT-INDUCED PHASE RESETTING
Previous studies on the Neurospora clock (Nakashima, 1985) have shown that the phases at which light pulses cause large phase shifts (circadian time [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] ) are phases at which the clock is practically unaffected by pulses of cycloheximide (but see Fig. 2 , below, which shows delays by cycloheximide in the late subjective night and the discussion thereof). This observation encouraged us to test whether cycloheximide could block lightinduced phase shifting, as the results could presumably be interpreted without compensating for additivity between light and cycloheximide phase resetting. Table 1 shows that cycloheximide ( 1 ~,g/ml) prevents the phase shift by light for both delay and advance phase shifts. This concentration of cycloheximide was previously shown to inhibit protein synthesis in Neurospora discs by 95% (Nakashima et al., 1981a) . Figure  1 illustrates that the phase shift by light is concurrently blocked by cycloheximide concentrations that inhibit translation. Two-hour pulses of cycloheximide were used in the experiments of Table 1 and Figure 1 , 1 hr before and 1 hr after the light pulse. Other experiments showed that even when cycloheximide is added to discs immediately after the light pulse and incubated with the discs for only 1 hr, the light-induced phase shift is essentially nullified (data not shown).
The results of Table 1 and Figure 1 indicate that cycloheximide prevents the phase shift by light. But is this effect of cycloheximide due to the drug's ability to inhibit protein synthesis, or is it due to some side effect of the drug? To distinguish between these alternatives, FIGURE 1. Inhibition of phase shifting and protein synthesis by 2-hr pulses of cycloheximide. Protein synthesis is measured by [14C]leucine incorporation as mentioned in &dquo;Methods&dquo; (crosses). Delay phase shifts (circles) and advance phase shifts (triangles) are the averages of six race tube determinations (SEM less than or equal to 0.4 hr for delay shifts; SEM less than or equal to 1.0 hr for advance shifts). Filled symbols are of samples that did not receive a light pulse, whereas open symbols are of samples that did receive a light pulse (2 min, 100 lux). Note that the scales for advance versus delay phase shifts are different. Light pulses were given at 50 hr after the light-to-dark transition for delay samples and at 54 hr for the advance samples. we tested bd, cyh-1, a single-gene mutant whose ribosomes are resistant to cycloheximide (Nakashima et al., 1981b; Pongratz and Klingmuller, 1973) . The data of Table 2 demonstrate that light-induced phase shifting of bd,cyh-I is not inhibited by cycloheximide. These data strongly suggest that the action of cycloheximide is via its impact upon protein synthesis, and is not due to some side effect.
LIGHT CANNOT PHASE-SHIFT AT ANY PHASE IN THE PRESENCE OF CYCLOHEXIMIDE
A trivial explanation of the preceding results is that light pulses are resetting the clock to a phase where cycloheximide can cause a counterbalancing phase shift. If this were true, then the simultaneous application of cycloheximide and light at some phases might not cause a net phase shift. But a counterbalancing action of cycloheximide would then be on the clock mechanism itself and would be very different from an action of cycloheximide on the input pathway of light. These alternative actions can be distinguished by testing the impact of cycloheximide on light-induced phase resetting at all phases throughout the circadian cycle. If cycloheximide makes the clock &dquo;blind&dquo; to light, then light pulses in the presence of the drug should not cause any further phase shift than does cycloheximide alone. FIGURE 2. Phase response curves (PRCs) to light, cycloheximide, and light plus cycloheximide. Abscissa plots the circadian time of the stimulus (time of the 2min light pulse, midpoint of 2-hr cycloheximide pulse); ordinate plots the phase shift in real hours (delay shifts as negative values, advance shifts as positive values). Treatments were given between 38 and 57 hr after the light-to-dark transition. Each point is the average of six race tube determinations; in all cases, SEM is less than or equal to 0.6 hr. Light pulses (2 min, 100 lux) are triangles; cycloheximide pulses (2 hr, 1 pg/ml) are open circles; and 2-hr cycloheximide pulses interrupted after 1 hr by a 2-min light pulse are filled circles. Figure 2 demonstrates that when cycloheximide and light pulses are presented together, the phase shift is determined by cycloheximide alone. As will be examined later (see &dquo;Discussion&dquo;), this result indicates that the light and cycloheximide phase shifts are not merely canceling each other and suggests that the inhibition by cycloheximide of lightinduced resetting is an effect upon the phototransduction pathway itself.
DOES INHIBITING TRANSCRIPTION ALSO INHIBIT LIGHT RESETTING?
Another important question to answer is whether the phototransduction pathway is regulated by transcription or translation. This is a particularly cogent question, as it is known that new messenger ribonucleic acid (mRNA) synthesis occurs in response to light in Neurospora (Chambers et al., 1985) . A partial answer to this question can be obtained by the use of inhibitors of transcription. 6-Methylpurine, an analogue of adenine, is known to inhibit RNA synthesis in Neurospora (Pendyala et al., 1979; Feldman and Dunlap, 1983; Dunlap, unpublished observations). We therefore tested the ability of 6-methylpurine to inhibit the phase shift by light. At concentrations up to 10 mM, 6-methylpurine did not inhibit light-induced phase delays. This concentration of 6-methylpurine inhibits RNA synthesis by 50-75% (Dr. Jay Dunlap, personal communication), suggesting that light-induced phase resetting is mediated by a translational mechanism. The results with 6-methylpurine, however, have been inconsistent; therefore, we regard the question of transcriptional versus translational control to be unanswered so far.
DISCUSSION
PHOTOTRANSDUCTION AND PROTEIN SYNTHESIS
Cycloheximide blocks light-induced phase resetting of the circadian clock in Neurospora. This result suggests that protein synthesis is somehow involved in the phototransduction pathway. Two alternatives to account for this involvement are reasonable. The first is that a protein (or proteins) with rapid turnover is a necessary link in the phototransduction pathway. In this case, the cellular level of this protein does not change during phototransduction, but its presence is necessary (e.g., to enzymatically convert some other messenger molecule). Cycloheximide blocks the synthesis of this protein, thereby allowing it to degrade rapidly. The protein is therefore unavailable to mediate phototransduction.
The second alternative is that light reception causes the synthesis of some protein (or proteins); this synthetic event is a necessary step in phototransduction of clock phase shifts. Consequently, cycloheximide &dquo;blinds&dquo; the clock to light signals by preventing the synthesis of this protein. At the present time, we do not know which of these alternatives is correct for Neurospora phototransduction.
In a similar approach, Eskin et al. (1984) have found that phase resetting of the clock in Aplysia eyes by serotonin or cyclic adenosine monophosphate (cAMP) is also blocked by protein synthesis inhibitors. They have identified a 34-kD protein whose synthesis is induced by serotonin or cAMP. The pattern of its synthesis is correlated with phase shifting (Yeung and Eskin, 1987) . Therefore, the experiments of Eskin and coworkers suggest that the cAMP transduction pathway in Aplysia may be based on the second alternative model described above (i.e., a transducing protein whose synthesis is necessary for resetting of the clock to occur).
How can this experimental approach be extended in the Neurospora system? We hope that it will be possible to study the alternatives above by the identification of candidate proteins by 2-D gel electrophoresis. If the second alternative is correct, then new proteins will be synthesized in response to light pulses, which should serve as candidates for further investigation of a potential role in phototransduction. In this context, light-regulated transcription and translation have already been reported for Neurospora (Chambers et al., 1985) . The synthesis of these macromolecules may, however, be involved in the light induction of carotenogenesis rather than of clock resetting (Harding and Mitchell, 1968; Rau et al., 1968; Schrott, 1980) . On the other hand, if the first alternative is correct, the 2-D gel electrophoresis technique can be used to search for proteins that are rapidly degraded after cycloheximide is added. Ultimately, the role of these candidate molecules in phototransduction can potentially be assessed by inactivating the genes for those proteins by homologous recombination (Paietta and Marzluf, 1985; Selker and Garrett, 1988 ) and measuring whether the clock is thereby blinded to light signals.
Yet another explanation exists for the data reported herein. If cycloheximide moves the state variables of the pacemaker very far from the limit cycle, the large impact of cycloheximide might overwhelm a smaller effect of light upon the state variables. The significance of this alternative is that cycloheximide might not affect the phototransduction pathway at all if it has a sufficiently large impact upon the pacemaker's state variables. This alternative explanation seems unlikely, as the dose response of cycloheximide inhibition of light resetting (Fig. 1) is very similar to the previously published dose response for cycloheximide-induced phase shifting (Nakashima et al., 1981 a) . If this last-mentioned explanation were true, the simplest prediction would be that the concentration threshold for cycloheximide inhibition of light resetting would be higher than the threshold for cycloheximide-induced resetting. The fact that it is not supports the interpretation that cycloheximide blocks the phototransduction mechanism itself, in addition to its ability to phase-shift the clock directly. Distinguishing among these alternatives, however, may ultimately depend on the gene inactivation experiments mentioned above.
BLUE-LIGHT PHOTOTRANSDUCTION: OTHER STUDIES
Cycloheximide is not the only treatment that can block light-induced phase resetting of the Neurospora clock. In a medium of pH 6.5 or higher, removing ammonium ions from the medium will prevent phase shifts by light pulses (Nakashima and Fujimura, 1982) . In a medium below pH 6.5, ammonium ions are not required for light resetting to occur. Inhibitors of Neurospora's plasma membrane proton adenosine triphosphatase (ATPase) will also block the phase shift by light in a medium at pH 6.7 (Nakashima, 1982;  those inhibitors are diethylstilbestrol and N,N'-dicyclohexylcarbodiimide). These results implicate proton fluxes across the plasma membrane in the phototransduction mechanism. Substantial changes of cytoplasmic pH, however, do not seem to be involved in phase shifting by light (Johnson, 1983 ).
The photoreceptor for Neurospora's clock seems to be a classical &dquo;blue-light photoreceptor&dquo; (Sargent and Briggs, 1967; Dharmananda, 1980) . Although blue-light photoreception has been studied intensively, controversy still exists over the nature of the photopigment, and almost nothing is known about subsequent steps in the phototransduction pathway (Senger, 1980) . We hope that the experiments reported here will allow the identification of a protein (or proteins) involved in the phototransduction mechanism for the circadian clock. Such a macromolecular &dquo;handle&dquo; on a clock transduction pathway may ultimately enable us to bypass the characterization of the photopigment in the search for the clock's mechanism.
CRITERIA FOR BLOCKING AGENTS
A powerful approach to characterizing the input pathway(s) to the clockwork is to use sitespecific blocking agents (Eskin, 1979; Johnson and Hastings, 1986) . Results of such experiments are most easily interpreted if the blocking agent does not itself cause phase resetting. If the blocking agent can reset the clock itself, however, the interpretation is more complicated. It has previously been considered sufficient that the blocking agent not cause a phase shift at the specific phase used to test for blocking the input pathway. This assumption is not necessarily valid, however. It could be that the input stimulus shifts the clock to a phase where the blocking agent has an effect on the pacemaker. Therefore, counterbalancing phase shifts are conceivable. In such a case, two separate, subtractive effects (one by the input stimulus and the second by the &dquo;blocking agent&dquo;) on the clockwork might be misinterpreted to be the result of a single input to the clock that is prevented by a putative blocking agent.
How are we to resolve the dilemma of counterbalancing phase shifts? We might test at many different circadian phases with both the stimulus and &dquo;blocking agent&dquo;-a dualtreatment phase response curve (PRC). If the agent in question is inhibiting the input pathway, then it should override that input at all phases of the clock. In this case, even if the blocking agent causes phase resetting at some circadian phases, the phase-shifting behavior of the blocking agent in conjunction with the input stimulus should parallel the resetting behavior of the blocking agent alone. This was the result obtained in the present report (see Fig. 2 ). If, on the other hand, the phase responsiveness of the clock to the &dquo;blocking agent&dquo; is different from that of the &dquo;blocking agent&dquo; plus input stimulus, it is possible that subtractive or counterbalancing phase resetting is occurring.
Although a dual-treatment PRC may not resolve all of the complications associated with the use of putative blocking agents that also reset the pacemaker, it should prove to be diagnostic for the problem of counterbalancing phase shifts. Consequently, dual-treatment PRCs may be useful in many blocking investigations of the circadian clock's mechanism.
